(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoic acid-D4;(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic Acid-D4; (+)-Fluprostenol-D4; [1R-[1?(Z),2?(1E,3R*),3?,5?]]-7-[3,5-Dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic Acid-D4; 16-(m-Trifluoromethylphenoxy)-17,18,19,20-tetranorprostaglandin F2?-D4; USP Travoprost Related Compound A-D4:
Travoprost Acid-d4 is a fully characterized chemical compound used as a reference standard of API Travoprost. The standard offered is compliant with regulatory guidelines. Travoprost Acid-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 54276-17-4 (non-labelled)
Related products
3-(4-(3-Chlorophenyl)piperazin-1-yl)propyl Isopropyl Carbonate
M.F.
M.W. 340.8
CAT# AR-T03395
CAS# NA
